Estrogen receptor beta treats Alzheimer's disease

Neural Regeneration Research

Volumn 8, Issue 5, 2013, Pages 420-426

  Tian, Zhu ^a   Fan, Jia ^b   Zhao, Yang ^a   Bi, Sheng ^a   Si, Li Hui ^b   Liu, Qun ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Akt signaling pathway; Alzheimer's disease; Amyloid ; Cognition; Estrogen; Estrogen receptor ; Inflammatory cytokines; Neural protection; Neural regeneration; Neurodegenerative diseases; Neuroregeneration; Photographs containing paper; Protein

Indexed keywords

AMYLOID BETA PROTEIN; ESTROGEN RECEPTOR BETA; INTERLEUKIN 1BETA; LENTIVIRUS VECTOR; MESSENGER RNA; PROTEIN KINASE B; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; HIPPOCAMPUS; IMMUNOFLUORESCENCE MICROSCOPY; INFLAMMATION; LEARNING; MALE; MEMORY; MORRIS WATER MAZE TEST; NERVE REGENERATION; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84890849981     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.05.005     Document Type: Article

References (39)

1. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137-152.
2. Bafakih FF, Daous YM, Gyure KA. Pathologic diagnosis of Alzheimer disease. W V Med J. 2011;107(3):30-33.
3. Liang K, Yang L, Yin C, et al. Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J Biol Chem. 2010;285(2):935-942.
4. Szego EM, Csorba A, Janáky T, et al. Effects of estrogen on beta-amyloid-induced cholinergic cell death in the nucleus basalis magnocellularis. Neuroendocrinology. 2011;93(2):90-105.
5. Bang Y, Lim J, Kim SS, et al. Aroclor1254 interferes with estrogen receptor-mediated neuroprotection against beta-amyloid toxicity in cholinergic SN56 cells. Neurochem Int. 2011;59(5):582-590.
6. Si ML, Long C, Chen MF, et al. Estrogen prevents β-amyloid inhibition of sympathetic α7-nAChR-mediated nitrergic neurogenic dilation in porcine basilar arteries. Acta Physiol (Oxf). 2011;203(1):13-23.
7. Bozzo C, Graziola F, Chiocchetti A, et al. Estrogen and beta-amyloid toxicity:role of integrin and PI3-K. Mol Cell Neurosci. 2010;45(2):85-91.
8. Germain D. Estrogen carcinogenesis in breast cancer. Endocrinol Metab Clin North Am. 2011;40(3):473-484
9. Stingl J. Estrogen and progesterone in normal mammary gland development and in cancer. Horm Cancer. 2011; 2(2):85-90.
10. Barone I, Brusco L, Fuqua SA. Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res. 2010;16(10):2702-2708.
11. Younes M, Honma N. Estrogen receptor β. Arch Pathol Lab Med. 2011;135(1):63-66.
12. Leong H, Riby JE, Firestone GL, et al. Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways. Mol Endocrinol. 2004;18(2):291-302.
13. Zhang G, Yanamala N, Lathrop KL, et al. Ligandindependent antiapoptotic function of estrogen receptor-beta in lung cancer cells. Mol Endocrinol. 2010; 24(9):1737-1747.
14. Si LH, Xu TM, Wang FZ, et al. X-box-binding protein 1-modified neural stem cells for treatment of Parkinson's disease. Neural Regen Res. 2012;7(10):736-740.
15. Valori CF, Ning K, Wyles M, et al. Development and Applications of Non-HIV-Based Lentiviral Vectors in Neurological Disorders. Curr Gene Ther. 2008;8:406-418.
16. Dodart JC, Marr RA, Koistinaho M, et al. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2005;102(4):1211-1216.
17. Peng KA, Masliah E. Lentivirus-expressed siRNA vectors against Alzheimer disease. Methods Mol Biol. 2010;614: 215-224.
18. Piedrahita D, Hernández I, López-Tobón A, et al. Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice. J Neurosci. 2010;30(42):13966-13976.
19. Dropulić B. Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research. Hum Gene Ther. 2011;22(6):649-657.
20. Staunstrup NH, Mikkelsen JG. Integrase-defective lentiviral vectors--a stage for nonviral integration machineries. Curr Gene Ther. 2011;11(5):350-362.
21. Dreyer JL. Lentiviral vector mediated gene transfer and RNA silencing technology in neuronal dysfunctions. Methods Mol Biol. 2010;614:3-35.
22. Geraerts M, Eggermont K, Hernandez-Acosta P, et al. Lentiviral vectors mediate efficient and stable gene transfer in adult neural stem cells in vivo. Hum Gene Ther. 2006;17(6):635-650.
23. Abordo-Adesida E, Follenzi A, Barcia C, et al. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther. 2005;16(6):741-751.
24. Wong LF, Goodhead L, Prat C, et al. Lentivirus-mediated gene transfer to the central nervous system:therapeutic and research applications. Hum Gene Ther. 2006;17(1): 1-9.
25. Loomes KM. Survival of an islet β-cell in type-2 diabetes:curbing the effects of amyloid cytotoxicity. Islets. 2011;3(1):38-39.
26. Giunta B, Ehrhart J, Obregon DF, et al. Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons:implications for HIV-associated neurocognitive disorders. Mol Brain. 2011; 4(1):23.
27. Fodero-Tavoletti MT, Villemagne VL, Rowe CC, et al. Amyloid-β:the seeds of darkness. Int J Biochem Cell Biol. 2011;43(9):1247-1251.
28. Mohamed A, Cortez L, de Chaves EP. Aggregation state and neurotoxic properties of alzheimer β-amyloid peptide. Curr Protein Pept Sci. 2011;12(3):235-257.
29. Hyman BT. Amyloid-dependent and amyloid-independent stages of Alzheimer disease. Arch Neurol. 2011;68(8): 1062-1064.
30. Stewart S, Cacucci F, Lever C. Which memory task for my mouse? A systematic review of spatial memory performance in the Tg2576 Alzheimer's mouse model. J Alzheimers Dis. 2011;26(1):105-126.
31. Rowe DD, Leonardo CC, Recio JA, et al. Human Umbilical Cord Blood Cells Protect Oligodendrocytes from Brain Ischemia through Akt Signal Transduction. J Biol Chem. 2012;287(6):4177-4187.
32. Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal. 2011;23(10):1515-1527.
33. Tsuji F, Oh-Hashi K, Kiuchi K. Differential effects of Akt pathway inhibitors on IL-1β-induced protein phosphorylation in human fibroblast-like synoviocytes. J Recept Signal Transduct Res. 2012;32(1):22-28.
34. Lou H, Fan P, Perez RG, et al. Neuroprotective effects of linarin through activation of the PI3K/Akt pathway in amyloid-β-induced neuronal cell death. Bioorg Med Chem. 2011;19(13):4021-4027.
35. Yin G, Li LY, Qu M, et al. Upregulation of AKT attenuates amyloid-β-induced cell apoptosis. J Alzheimers Dis. 2011; 25(2):337-345.
36. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
37. Nabeshima T, Nitta A. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. Tohoku J Exp Med. 1994;174(3):241-249.
38. Liu L, Orozco IJ, Planel E, et al. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis. 2008;31(1):46-57.
39. Finch CE, Marchalonis JJ. Evolutionary perspectives on amyloid and inflammatory features of Alzheimer disease. Neurobiol Aging. 1996;17(5):809-815.